Jinyuan Zhang

Dr. Jinyuan Zhang

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 July 2025 in Journal of Advanced Research
Verified
Journal Article
Open access
JLJiaqi Lin
Jiaqi Lin
XZXuejiao Zeng
Xuejiao Zeng
SZSu Zehua
Su Zehua
LLLijun Liao Liao
Lijun Liao Liao
YYYongze Yu
Yongze Yu
LLLijun Liao
Lijun Liao
Neuropathic pain, is a chronic condition stemming from nervous system injuries. The farnesoid X receptor (FXR), primarily expressed in the liver and intestines, plays a crucial role in regulating bile acids and lipids metabolism. Emerging evidence suggests that bile acids might influence neural function through FXR modulation. To investigate the specific role of intestinal FXR in the modulation of neuropathic pain. A neuropathic pain model was established in mice through ligation of the lumbar 4 spinal nerve (SNL). FXR expression was detected in the distal ileum and spinal cord. The baseline pain threshold and pain-related behaviors were evaluated in FXR gene knockout (Fxr -/-) mice. To examine the pharmacological role of FXR activation, obeticholic acid (INT-747, 10 mg/kg/day for 14 days) and HDCA (20 mg/kg/day for 21 days) were administered via intragastric gavage, and changes in pain behaviors were monitored. Additionally, the bile acid profiles of Fxr -/- mice and SNL mice were also analyzed. Furthermore, the effects of FXR on intestinal barrier function, gut microbiota composition, and systemic inflammation regulation were systematically evaluated. Neuropathic pain was associated with reduced FXR levels in the gut and spinal cord, accompanied by decreased bile acid levels, especially HDCA. FXR deficiency lowered the pain threshold, whereas treatment with INT-747 or HDCA relieved pain in SNL mice. Activation of FXR restored intestinal barrier integrity, balanced microbiota, reduced inflammation, and decreased microglial activation. HDCA alleviated pain by modulating FXR activity, increasing peroxisome proliferator-activated receptor gamma (PPAR-γ) expression and reducing abnormal matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-2 (MMP-9) activation. This research highlights a critical link between FXR levels and neuropathic pain. Manipulating FXR activity with INT-747 or HDCA not only reduced pain severity but also strengthened intestinal barriers and dampened inflammatory responses, suggesting the potential of FXR-targeted therapies in effectively managing neuropathic pain.

2 June 2025 in European Spine Journal
Verified
Journal Article
Closed access
PDF file
YYYongze Yu
Yongze Yu
WXWen Xu
Wen Xu
LLLijun Liao Liao
Lijun Liao Liao
XZXuejiao Zeng
Xuejiao Zeng
SZSu Zehua
Su Zehua
JZJinyuan Zhang
Jinyuan Zhang

17 September 2025 in Journal of Medical Microbiology
Verified
Journal Article
Open access
SZSu Zehua
Su Zehua
JLJiaqi Lin
Jiaqi Lin
XZXuejiao Zeng
Xuejiao Zeng
LLLijun Liao Liao
Lijun Liao Liao
QHQianhao Hou
Qianhao Hou
LLLijun Liao
Lijun Liao
Introduction. This study centres on how coronavirus disease 2019 (COVID-19) disrupts the intestinal microbiota and amplifies systemic inflammation and evaluates ozone water enemas as a strategy to restore gut microbial balance and activate the SIRT1 (silent information regulator of transcription 1)-Nrf2 (nuclear factor erythroid 2-related factor 2)/HO-1 (heme oxygenase-1) pathway for alleviating post-viral sequelae. Our findings demonstrate that ozone water intervention markedly improves the intestinal microenvironment in mice receiving COVID-19 patient-derived microbiota and attenuates systemic inflammation, offering a viable adjunctive approach for COVID-19 management. Hypothesis. Despite significant progress in reducing the incidence of COVID-19, its long-term consequences, including hepatic dysfunction, pulmonary injury and gut microbiota dysbiosis, remain challenging. While ozonated water enema therapy has shown efficacy in alleviating inflammation and neutralizing oxidative stress, the precise mechanisms by which ozonated water attenuates COVID-19 progression are not fully understood. We hypothesized that ozonated water enemas could enrich gut microbiota composition in COVID-19 patients, thereby optimizing the gut environment following faecal transplantation in a murine model. Aim. The overarching aim of this investigation was to ascertain whether ozonated water enemas could exert a salutogenic effect on the gut microbiota in a mouse model, as well as on the holistic gut and systemic health of critically ill COVID-19 patients subsequent to faecal transplantation. Methodology. The entire experiment was conducted over a 14-day period. WT mice were randomly allocated into three groups: Sham, FMT (faecal microbiota transplantation) and FMT+O3 (FMT with ozonewater enema treatment). Mid-stage faecal specimens were collected from 21 severe COVID-19 patients and randomly divided into seven subgroups (three specimens per subgroup). These specimens were transplanted into the WT mice of the FMT and FMT+O3 groups via faecal gavage on days 1 through 7. The healthy control group (Sham) received oral administration of ddH₂O instead. Starting on day 8 post-transplantation, the FMT+O3 group underwent ozone water enema treatment for seven consecutive days. During this treatment period, assessments were performed to evaluate intestinal barrier function, inflammatory changes and alterations in gut microbiota. Additionally, improvements in intestinal, hepatic, pulmonary and systemic lesions were examined. Results. Our findings indicate that ozonated water enemas modulate the SIRT1-Nrf2/HO-1 pathway, significantly enhancing the intestinal environment in mice that received FMT from COVID-19 patients. This intervention increased microbiota populations, strengthened intestinal barrier integrity and reduced intestinal and systemic inflammatory responses. Conclusion. The results highlight the potential of ozonated water enemas as a therapeutic option for COVID-19 patients, particularly in optimizing intestinal microbiota and mitigating inflammatory responses through SIRT1-Nrf2/HO-1 pathway modulation. This approach offers a novel strategy for addressing residual effects of COVID-19.

19 January 2021 in Journal of Clinical Gastroenterology
Verified
Journal Article
Open access
JDJunyi Duan
Junyi Duan
XCXin Chen
Xin Chen
YWYixing Wang
Yixing Wang
GZGang Zhao
Gang Zhao
JLJing Li
Jing Li
YCYuelai Chen
Yuelai Chen
Aims of This Study: A randomized clinical trial was undertaken to investigate the efficacy of acupoint catgut embedding (ACE) as adjunctive therapy to tauroursodeoxycholic acid (TUDCA) therapy on gallbladder emptying and clinical symptoms in patients with gallstone disease. Materials and Methods: Between August 2018 and January 2019, 70 patients with gallstones in our hospital were enrolled in this prospective clinical trial. All the patients were randomly divided into the ACE group (ACE+TUDCA treatment for 8 wk) and the Sham group (Sham ACE+TUDCA treatment for 8 wk). In the ACE group, all the patients were nightly given ACE every 2 weeks, and in 2 groups, every patient took TUDCA 500 mg at bedtime. The parameters about gallbladder emptying were detected by ultrasound before and after the treatment, and the clinical symptom scores were recorded at the same time points. Results: A total of 63 patients with gallstone disease were included in our study, with 33 patients in the ACE group and 30 patients in the Sham group. In the ACE group, the empty volume (EV) and gallbladder ejection fraction (GBEF) were improved after treatment (P<0.05). Almost every symptom score (except symptom 7, P=0.15) and total score were decreased (P<0.05). In the Sham group, the symptom 1, 2, 4, 5 scores, and total score were significantly decreased (P<0.05). Moreover, the residual volume in the ACE group was significantly lower than in the Sham group (P=0.008). The EV and GBEF in the ACE group were higher than that in the Sham group (P<0.05). The score of symptom 6 in the ACE group was lower than that in the Sham group (P=0.008). Conclusion: ACE therapy could more effectively improve the gallbladder emptying with a shorter treatment course. Therefore, ACE+TUDCA therapy might be a time-saving treatment for gallstones.

19 May 2023 in Frontiers in Immunology
Verified
Journal Article
Open access
ACAnning Chen
Anning Chen
ZSZhun Sun
Zhun Sun
DSDonglin Sun
Donglin Sun
MHMeiying Huang
Meiying Huang
HFHongwei Fang
Hongwei Fang
GQGuojun Qian
Guojun Qian
Background: Idiopathic Pulmonary Fibrosis (IPF) can be described as a debilitating lung disease that is characterized by the complex interactions between various immune cell types and signaling pathways. Chromatin-modifying enzymes are significantly involved in regulating gene expression during immune cell development, yet their role in IPF is not well understood.Methods: In this study, differential gene expression analysis and chromatin-modifying enzyme-related gene data were conducted to identify hub genes, common pathways, immune cell infiltration, and potential drug targets for IPF. Additionally, a murine model was employed for investigating the expression levels of candidate hub genes and determining the infiltration of different immune cells in IPF.Results: We identified 33 differentially expressed genes associated with chromatin-modifying enzymes. Enrichment analyses of these genes demonstrated a strong association with histone lysine demethylation, Sin3-type complexes, and protein demethylase activity. Protein-protein interaction network analysis further highlighted six hub genes, specifically KDM6B, KDM5A, SETD7, SUZ12, HDAC2, and CHD4. Notably, KDM6B expression was significantly increased in the lungs of bleomycin-induced pulmonary fibrosis mice, showing a positive correlation with fibronectin and α-SMA, two essential indicators of pulmonary fibrosis. Moreover, we established a diagnostic model for IPF focusing on KDM6B and we also identified 10 potential therapeutic drugs targeting KDM6B for IPF treatment.Conclusion: Our findings suggest that molecules related to chromatin-modifying enzymes, primarily KDM6B, play a critical role in the pathogenesis and progression of IPF.

24 October 2025 in Pain
Verified
Journal Article
Open access
XZXuejiao Zeng
Xuejiao Zeng
JLJiaqi Lin
Jiaqi Lin
BLBotao Liu
Botao Liu
SZSu Zehua
Su Zehua
YYYongze Yu
Yongze Yu
LLLijun Liao
Lijun Liao
Neuropathic pain is a chronic, intractable condition characterized by a complex pathogenesis. Hydrogen-rich water (HRW) has been reported to have possible analgesic properties, but the underlying mechanisms remain unclear. To investigate the effects of HRW, we utilized an L4 spinal nerve ligation (SNL) model in both male and female mice. Pain behaviors were quantitatively assessed using paw withdrawal threshold, paw withdrawal latency, and acetone response tests. Fecal microbiota composition was analyzed through 16S rRNA sequencing, and serum bile acids were assessed by liquid chromatography–mass spectrometry. The expression of bile acid membrane receptor Takeda G-protein-coupled receptor 5 (TGR5) and autophagy markers were evaluated in spinal cord, dorsal root ganglia, and colon through biochemistry experiments. Autophagic structures were examined using transmission electron microscopy. We further validated the roles of TGR5 and autophagy in neuropathic pain through experiments using rapamycin treatment and TGR5 knockout mouse models. The effect of HRW on intestinal barrier function was also tested. We found that HRW effectively ameliorated behavioral deficits associated with SNL-induced neuropathic pain. In addition, HRW facilitated the repair of the damaged gut barrier, restored the disrupted intestinal microbiota, and modulated bile acid metabolism in SNL mice. Interventions with hyodeoxycholic acid and deoxycholic acid produced analgesic effects similar to those of HRW. Takeda G-protein-coupled receptor 5 knockdown reversed the therapeutic effects of HRW and rapamycin. Mechanistically, HRW alleviates neuropathic pain by modulating bile acid metabolites linked to intestinal microbiota and directly or indirectly activating TGR5 in the spinal cord, dorsal root ganglia, and colon, thereby promoting autophagy.